Q1 2024 · 13F-HR
Redmile Group, LLCholdings as filed
Filed 2024-05-15 · accession 0001104659-24-062013
$2.72B
Reported value
77
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $268.4M | 9.85% | 1,508,250 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $156.2M | 5.73% | 13,257,286 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $120.7M | 4.43% | 4,889,554 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $114.0M | 4.18% | 6,419,610 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $96.7M | 3.55% | 13,169,057 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $95.9M | 3.52% | 4,551,556 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $83.3M | 3.06% | 5,296,643 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $69.7M | 2.56% | 1,734,089 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $68.6M | 2.52% | 15,269,217 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $68.5M | 2.51% | 5,073,049 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $67.0M | 2.46% | 16,380,327 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $65.9M | 2.42% | 4,483,016 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $63.6M | 2.33% | 1,163,241 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $62.1M | 2.28% | 1,879,617 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $58.5M | 2.15% | 5,560,798 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $58.1M | 2.13% | 1,037,780 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $50.2M | 1.84% | 5,615,489 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $48.2M | 1.77% | 4,326,509 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $47.6M | 1.75% | 935,252 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $47.0M | 1.72% | 1,858,702 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $46.9M | 1.72% | 8,253,316 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $46.1M | 1.69% | 3,097,220 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $43.8M | 1.61% | 2,027,669 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $40.5M | 1.49% | 922,678 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $40.2M | 1.48% | 1,261,427 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $39.5M | 1.45% | 5,503,190 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $38.4M | 1.41% | 560,926 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $37.6M | 1.38% | 896,454 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $36.6M | 1.34% | 552,506 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $35.7M | 1.31% | 632,464 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $31.3M | 1.15% | 969,621 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $30.5M | 1.12% | 3,729,983 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $29.8M | 1.09% | 262,371 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $29.6M | 1.09% | 3,072,478 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $28.6M | 1.05% | 87,255 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $26.6M | 0.98% | 3,962,602 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $26.4M | 0.97% | 2,264,566 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $23.8M | 0.87% | 65,435 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $22.3M | 0.82% | 679,172 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $21.3M | 0.78% | 1,604,515 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $18.2M | 0.67% | 1,283,735 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $17.5M | 0.64% | 52,487 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $16.2M | 0.59% | 31,223 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $16.0M | 0.59% | 2,194,560 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $15.9M | 0.58% | 1,114,034 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $15.5M | 0.57% | 43,246 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $14.8M | 0.54% | 5,755,075 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $14.5M | 0.53% | 2,074,350 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $12.4M | 0.46% | 36,949 | Common | SOLE |
| 74340E103 | PGNY | PROGYNY INC | $12.2M | 0.45% | 320,864 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $11.9M | 0.44% | 2,164,126 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $11.8M | 0.43% | 29,546 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $11.3M | 0.42% | 161,600 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $11.2M | 0.41% | 83,849 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $11.1M | 0.41% | 20,707 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $11.0M | 0.40% | 3,031,009 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $11.0M | 0.40% | 676,039 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $10.7M | 0.39% | 113,060 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $10.0M | 0.37% | 44,613 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $9.5M | 0.35% | 2,016,302 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $9.1M | 0.33% | 155,000 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $8.6M | 0.32% | 3,308,798 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $7.6M | 0.28% | 442,826 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $6.9M | 0.25% | 2,074,372 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $6.4M | 0.24% | 9,263,309 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $6.4M | 0.23% | 1,440,725 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $5.9M | 0.22% | 662,398 | Common | SOLE |
| H00263105 | ACIU | AC IMMUNE SA | $5.9M | 0.22% | 2,007,031 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $5.8M | 0.21% | 114,341 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $4.3M | 0.16% | 3,451,076 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $2.3M | 0.08% | 1,046,587 | Common | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $2.0M | 0.07% | 1,608,089 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $1.4M | 0.05% | 1,907,969 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $1.1M | 0.04% | 715,607 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $1.1M | 0.04% | 411,631 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $757,404 | 0.03% | 1,063,769 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $433,776 | 0.02% | 171,453 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.